Items where contributor is "Pfeil, Alena"
2015Pfeil, Alena M. and Imfeld, P. and Pettengell, R. and Jick, S. S. and Szucs, Thomas D. and Meier, Christoph R. and Schwenkglenks, Matthias. (2015) Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia : insights from the UK Clinical Practice Research Datalink (CPRD). Annals of hematology, 94 (3). pp. 421-429. Pfeil, Alena M. and Allcott, Kim and Pettengell, Ruth and von Minckwitz, Gunter and Schwenkglenks, Matthias and Szabo, Zsolt. (2015) Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer : a systematic review. Supportive care in cancer, Vol. 23, H. 2. pp. 525-545. 2014Pavic, Matea and Pfeil, Alena M. and Szucs, Thomas D.. (2014) Estimating the potential annual welfare impact of innovative drugs in use in Switzerland. Frontiers in public health, 2. Article 48. Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570. Pfeil, Alena M. and Vulsteke, Christof and Paridaens, Robert and Dieudonné, Anne-Sophie and Pettengell, Ruth and Hatse, Sigrid and Neven, Patrick and Lambrechts, Diether and Szucs, Thomas D. and Schwenkglenks, Matthias and Wildiers, Hans. (2014) Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC cancer, Vol. 14. p. 201. 2013Gutzwiller, Florian S. and Pfeil, Alena M. and Comin-Colet, Josep and Ponikowski, Piotr and Filippatos, Gerasimos and Mori, Claudio and Braunhofer, Peter G. and Szucs, Thomas D. and Schwenkglenks, Matthias and Anker, Stefan D.. (2013) Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose : FAIR-HF sub-analysis. International journal of cardiology, Vol. 168, H. 4. pp. 3878-3883. Schwenkglenks, Matthias and Bendall, Kate Louise and Pfeil, Alena M. and Szabo, Zsolt and Pettengell, Ruth. (2013) External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & lymphoma, Vol. 54, H. 11. pp. 2426-2432. Lothgren, Mickael and Ribnicsek, Erna and Schmidt, Louise and Habacher, Wolfgang and Lundkvist, Jonas and Pfeil, Alena M. and Biteeva, Irina and Vrouchou, Polina and Bracco, Andrea. (2013) Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland. European journal of hospital pharmacy. Science and practice, Vol. 20, H. 4. pp. 227-231. Szucs, Thomas D. and Pfeil, Alena M.. (2013) A systematic review of the cost effectiveness of herpes zoster vaccination. PharmacoEconomics, Vol. 31, no. 2. pp. 125-136. Bollhalder, Lea and Pfeil, Alena M. and Tomonaga, Yuki and Schwenkglenks, Matthias. (2013) A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clinical nutrition, Vol. 32, H. 2. pp. 213-223. 2012Pfeil, Alena M. and Kressig, Reto W. and Szucs, Thomas D.. (2012) Alzheimer's dementia : budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland. Swiss medical weekly, Vol. 142 , w13676. 2010Pfeil, Alena and Mutsch, Margot and Hatz, Christoph and Szucs, Thomas D.. (2010) A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health, 10. p. 402. |
